Research Topics
Genomes and Genes
| Robert C GreenSummaryAffiliation: Boston University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Risk of dementia among white and African American relatives of patients with Alzheimer diseaseRobert C Green
Genetics Program and Alzheimer s Disease Center, Boston University School of Medicine, 715 Albany St, L 320, Boston, MA 02118, USA
JAMA 287:329-36. 2002..Family studies of probands with AD offer an opportunity to evaluate lifetime risk of dementia among relatives of these probands...
Disclosure of APOE genotype for risk of Alzheimer's diseaseRobert C Green
Boston University School of Medicine, Boston, MA 02118, USA
N Engl J Med 361:245-54. 2009..We examined the effect of genotype disclosure in a prospective, randomized, controlled trial...
Depression as a risk factor for Alzheimer disease: the MIRAGE StudyRobert C Green
Department of Neurology, Genetics Program, Boston University School of Medicine, MA 02118, USA
Arch Neurol 60:753-9. 2003..Depression symptoms may be associated with the development of Alzheimer disease (AD)...
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trialRobert C Green
Department of Neurology, Boston University School of Medicine, 72 E Concord St, L 320, Boston, MA 02118, USA
JAMA 302:2557-64. 2009..Tarenflurbil, a selective Abeta(42)-lowering agent, demonstrated encouraging results on cognitive and functional outcomes among mildly affected patients in an earlier phase 2 trial...
Primary prevention trials in Alzheimer diseaseRobert C Green
Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA
Neurology 67:S2-5. 2006..Primary prevention trials for AD present many design challenges. In most situations, secondary prevention trials provide the most feasible first step toward primary prevention...
Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trialJ Scott Roberts
Departments of Neurology and Medicine Genetics Program, Boston University School of Medicine, 715 Albany Street B 7800, Boston, MA 02118, USA
Genet Med 6:197-203. 2004..This study's main purposes were to estimate interest in such testing and to examine demographic predictors of study participation...
Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease familiesKaren T Cuenco
Department of Medicine, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA
Neurobiol Aging 32:249-56. 2011..Results for the other MRI traits were unremarkable. This study highlights the potential value of neuroimaging endophenotypes as a tool for finding genes influencing AD pathogenesis...
Predicting cognitive decline and conversion to Alzheimer's disease in older adults using the NAB List Learning testBrandon E Gavett
Department of Neurology, Boston University School of Medicine, Boston, Massachusetts 02118 2526, USA
J Int Neuropsychol Soc 16:651-60. 2010..The predictive validity of the NAB List Learning algorithm makes it a clinically useful tool for the assessment of older adults...
Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer diseasePorat M Erlich
Department of Medicine Genetics Program, Boston University School of Medicine, Boston, MA 02118, USA
Neurobiol Aging 33:1015.e7-23. 2012..Our results suggest that low serum paraoxonase activity is a risk factor for AD. Furthermore, multiple variants in PON influence serum paraoxonase activity and their effects may be synergistic...
Effect of Alzheimer disease genetic risk disclosure on dietary supplement useJacqueline A Vernarelli
Department of Neurology, Boston University School of Public Health, Boston, MA, USA
Am J Clin Nutr 91:1402-7. 2010..Little is known about whether APOE genotype disclosure would actually prompt changes in nutrition behaviors among at-risk individuals...
Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL studyL Adrienne Cupples
Departments of Biostatistics and Epidemiology, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA
Genet Med 6:192-6. 2004..The protocol presents risk information as cumulative incidence curves. This article describes how these curves were estimated...
Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's diseaseMichael R Cassidy
Department of Neurology, Boston University School of Medicine, Boston, MA, USA
Alzheimers Dement 4:406-13. 2008..The purpose of this study was to compare the psychological impact of using these two different types of genetic information to disclose genetic risk for AD to family members of affected patients...
Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) studyJ Scott Roberts
Department of Neurology, Boston University School of Medicine, MA 02118, USA
J Geriatr Psychiatry Neurol 18:250-5. 2005....
Voxelwise genome-wide association study (vGWAS)Jason L Stein
Laboratory of Neuro Imaging, Department of Neurology, University of California, Los Angeles School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095 1769, USA
Neuroimage 53:1160-74. 2010..These genes have high relevance to brain structure. This is the first voxelwise genome wide association study to our knowledge, and offers a novel method to discover genetic influences on brain structure...
Lower-extremity function in cognitively healthy aging, mild cognitive impairment, and Alzheimer's diseaseLaura H Eggermont
Alzheimer s Disease Clinical and Research Program, Boston University School of Medicine, Boston, MA 02118 2526, USA
Arch Phys Med Rehabil 91:584-8. 2010..To examine differences in lower-extremity function in cognitive healthy older persons, older persons with mild cognitive impairment (MCI), and older persons with Alzheimer's disease (AD)...
Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer diseaseKaren T Cuenco
Genetics Program, Department of Medicine, Room L320, Boston University School of Medicine, 715 Albany St, Boston, MA 02118, USA
Arch Neurol 65:1640-8. 2008....
Magnetic resonance imaging traits in siblings discordant for Alzheimer diseaseKaren T Cuenco
Department of Medicine, Boston University Schools of Medicine and Public Health, Boston, MA 02118, USA
J Neuroimaging 18:268-75. 2008..We evaluated semi-quantitative MRI measures as endophenotypes for genetic studies by assessing their association with AD in families from the Multi-Institutional Research in Alzheimer Genetic Epidemiology (MIRAGE) Study...
Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL StudySerena Chao
Department of Medicine Geriatrics Section Boston University School of Medicine, Boston, MA 02118, USA
Alzheimer Dis Assoc Disord 22:94-7. 2008..Despite lack of preventive measures for AD, knowledge of APOE genotype, numerical lifetime risk, or both, influences health behavior...
Geriatric performance on an abbreviated version of the Boston naming testAngela L Jefferson
Alzheimer s Disease Center and Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
Appl Neuropsychol 14:215-23. 2007..001). Geriatric normative data therefore suggest that sex, race, and education are all associated with naming performance, and these variables should be taken into consideration when interpreting geriatric BNT-30 performance...
Clock drawing test ratings by dementia specialists: interrater reliability and diagnostic accuracyAnil K Nair
Alzheimer s Disease Center, Boston University School of Medicine, Boston, USA
J Neuropsychiatry Clin Neurosci 22:85-92. 2010..Based on rating systems, clock drawing test scoring by dementia clinicians had excellent interrater reliability and sensitivity for differentiating the mild Alzheimer's disease subjects from comparison subjects...
Association between apolipoprotein E genotype and Alzheimer disease in African American subjectsNeill R Graff-Radford
Genetics Program L 320, Boston University School of Medicine, 715 Albany St, Boston, MA 02118, USA
Arch Neurol 59:594-600. 2002..The association between Alzheimer disease (AD) and genotypes at the apolipoprotein E (APOE) locus has been confirmed in numerous populations worldwide, but appears to be inconsistent in African American subjects...
Diagnostic utility of the NAB List Learning test in Alzheimer's disease and amnestic mild cognitive impairmentBrandon E Gavett
Department of Neurology, Boston University School of Medicine, Boston, Massachusetts 02118 2526, USA
J Int Neuropsychol Soc 15:121-9. 2009..58 to .92 and univariate specificity values ranged from .52 to .97. Multivariate ordinal regression produced a model that classified individuals with 80% accuracy and good predictive power. (JINS, 2009, 15, 121-129.)...
Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE studyKathryn L Lunetta
Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA
Alzheimer Dis Assoc Disord 21:85-91. 2007..In the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study of AD-discordant siblings, MRI traits are heritable and are potential endophenotypes for genetic association studies...
Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utilityIlona M Kopits
Boston University School of Medicine, Boston, Massachusetts, USA
Genet Test Mol Biomarkers 15:871-5. 2011..The increased availability of genetic tests for common, complex diseases, such as Alzheimer's disease (AD), raises questions about what people are willing to pay for these services...
A comprehensive genetic association study of Alzheimer disease in African AmericansMark W Logue
Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA
Arch Neurol 68:1569-79. 2011..To evaluate the association of genetic variation with late-onset Alzheimer disease (AD) in African Americans, including genes implicated in recent genome-wide association studies of whites...
Predictors of subjective memory complaint in cognitively normal relatives of patients with Alzheimer's diseaseDavid H Tsai
Boston University School of Medicine, 715 Albany St, L-320, Boston, MA 02118, USA
J Neuropsychiatry Clin Neurosci 18:384-8. 2006..Clinicians counseling family members of Alzheimer's disease patients who express subjective memory complaint should first evaluate cognition. If cognition is intact, depression should be considered...
Test-retest stability on the WRAT-3 reading subtest in geriatric cognitive evaluationsLee Ashendorf
Department of Neurology, Alzheimer s Disease Center, Boston University School of Medicine, Boston, MA 02118 2526, USA
J Clin Exp Neuropsychol 31:605-10. 2009..Results indicated that WRAT-3 Reading scores are appropriate for use with older adults, though the use of categorical descriptors to describe premorbid ability based on these scores is not supported...
A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer diseaseWinston W Chung
Boston University School of Medicine, 715 Albany Street, R 7800, Boston, MA 02118, USA
Alzheimer Dis Assoc Disord 23:50-6. 2009....
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's diseaseDavid A Wolk
Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA
Proc Natl Acad Sci U S A 107:10256-61. 2010....
The Framingham Brain Donation Program: neuropathology along the cognitive continuumRhoda Au
Department of Neurology, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA
Curr Alzheimer Res 9:673-86. 2012..We observed that an aggregate ischemic injury score was significantly higher in persons with a CDR score of 0.5 than in normal controls...
Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's diseaseSusan Hiraki
Dept of Neurology, Boston University School of Medicine, Boston, MA, USA
J Genet Couns 18:130-6. 2009..001) and being Caucasian (p = 0.02). These results are the first to demonstrate the association between family history and risk perception in persons volunteering for genetic susceptibility testing for a common complex disease...
Polymorphisms in the PON gene cluster are associated with Alzheimer diseasePorat M Erlich
Department of Medicine Genetics Program, Boston University School of Medicine, Boston, MA 02118, USA
Hum Mol Genet 15:77-85. 2006..The most significantly associated haplotype comprised SNPs in the region spanning the -161[C/T] SNP (P=0.00009). Our results demonstrate association between AD and variants in the PON gene cluster in Caucasians and African Americans...
Clock drawing performance in cognitively normal elderlyEmily J Hubbard
Alzheimer s Disease Clinical and Research Program, Department of Neurology, Boston University School of Medicine, Boston, MA, USA
Arch Clin Neuropsychol 23:295-327. 2008..Our results may serve as useful comparisons for clinicians wishing to know whether their patients perform in the general range of cognitively normal elderly...
The beliefs, motivations, and expectations of parents who have enrolled their children in a genetic biorepositoryErin D Harris
Department of Medicine, Division of Genetics and Program in Genomics, Children s Hospital Boston, Boston, Massachusetts, USA
Genet Med 14:330-7. 2012..The aim of this study was to understand the views of the parents who enrolled their children in a genomic repository in which IRRs will be returned...
Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer diseaseJ Scott Roberts
Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
Alzheimer Dis Assoc Disord 17:86-93. 2003..3, p < 0.01). Findings suggest that genetic susceptibility testing is of interest to individuals at risk for AD for a variety of reasons, even in the relative absence of available treatments...
Genetic susceptibility for Alzheimer's disease: why did adult offspring seek testing?Ann C Hurley
Brigham and Women s Hospital, Center for Excellence in Nursing Practice, and School of Nursing, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA
Am J Alzheimers Dis Other Demen 20:374-81. 2005....
Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: the Genetic Counseling/lifestyle Change (GC/LC) Study for Diabetes PreventionRichard W Grant
Division of General Medicine, Massachusetts General Hospital, Boston, MA, USA
Clin Trials 8:609-15. 2011..The efficacy of diabetes genetic risk testing to motivate behavior change for diabetes prevention is currently unknown...
Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE StudyAgustin G Yip
Department of Medicine Genetics Program, Boston University School of Medicine, 715 Albany Street, Boston MA 02118 2526, USA
BMC Geriatr 5:2. 2005..We sought examine the association between NSAID use and risk of AD, and potential effect modification by APOE-epsilon4 carrier status and ethnicity...
Differences between African Americans and whites in their perceptions of Alzheimer diseaseJ Scott Roberts
Department of Neurology, Boston University School of Medicine, Massachusetts, USA
Alzheimer Dis Assoc Disord 17:19-26. 2003..Health psychologic research suggests that such differences in illness perceptions could shape response to disease burden, assessment and diagnosis, and available health care options...
The adult galactosemic phenotypeSusan E Waisbren
Children s Hospital Boston, Boston, MA, USA
J Inherit Metab Dis 35:279-86. 2012..Data on how individuals with galactosemia fare as adults will improve our ability to predict disease progression...
Exploring concordance and discordance for return of incidental findings from clinical sequencingRobert C Green
Division of Genetics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Genet Med 14:405-10. 2012..The aim of this study was to explore specific conditions and types of genetic variants that specialists in genetics recommend should be returned as incidental findings in clinical sequencing...
Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibilityChristopher A Cassa
Children s Hospital Informatics Program, Children s Hospital Boston, Boston, Massachusetts 02115, USA
Genome Res 22:421-8. 2012..Additionally, if the growth rate from the previous 4 yr continues, we estimate that the total number of disease-associated variants will grow 37% over the next 4 yr...
Navigating a research partnership between academia and industry to assess the impact of personalized genetic testingLisa Soleymani Lehmann
Department of Medicine and Center for Bioethics, Brigham and Women s Hospital, Boston, Massachusetts, USA
Genet Med 14:268-73. 2012....
Cognitive correlates of HVOT performance differ between individuals with mild cognitive impairment and normal controlsAngela L Jefferson
Alzheimer s Disease Center and Department of Neurology, Boston University School of Medicine, Robinson Complex, Suite 7800, 715 Albany Street, Boston, MA 02118 2526, USA
Arch Clin Neuropsychol 21:405-12. 2006....
Genetic susceptibility testing for chronic disease and intention for behavior change in healthy young adultsJason L Vassy
Section of General Internal Medicine, VA Boston Healthcare System, 150 Huntington Avenue, Bldg 9, STE 425, Boston, MA, 02130, USA
J Community Genet 4:263-71. 2013..To be effective, genetic risk testing in young adults may need to be coupled with other strategies to enable behavior change...
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderlyApril J Ho
Laboratory of Neuroimaging, Department of Neurology, University of California School of Medicine, Los Angeles, CA 90095, USA
Proc Natl Acad Sci U S A 107:8404-9. 2010..These brain maps reveal that a commonly carried susceptibility allele for obesity is associated with structural brain atrophy, with implications for the health of the elderly...
Development and validation of a computational method for assessment of missense variants in hypertrophic cardiomyopathyDaniel M Jordan
Division of Genetics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
Am J Hum Genet 88:183-92. 2011....
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behaviorCathleen D Zick
University of Utah, Salt Lake City, USA
Health Aff (Millwood) 24:483-90. 2005..If genetic testing for Alzheimer's risk assessment becomes common, it could trigger adverse selection in long-term care insurance...
Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer diseaseSusan LaRusse
Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, USA
Genet Med 7:48-53. 2005..9%, P < 0.0001). CONCLUSIONS: These data suggest that risk estimates incorporating negative genetic test results affect perceptions of disease susceptibility more strongly than identical estimates based on family history alone...
Predictive genetic testing for Alzheimer's disease: impact upon risk perceptionTheresa M Marteau
Psychology and Genetics Research Group, Institute of Psychiatry, King s College London, London, UK
Risk Anal 25:397-404. 2005..e., perceiving risks as equal to or lower than population risks of AD), although this possibility should be assessed in other testing contexts...
Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experienceKurt D Christensen
Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan 48109 0471, USA
Genet Med 10:207-14. 2008..To describe how investigators in a multisite randomized clinical trial addressed scientific and ethical issues involved in creating risk models based on genetic testing for African American participants...
Differences between African Americans and Whites in their attitudes toward genetic testing for Alzheimer's diseaseYvonne G Hipps
Department of Pharmacology, Morehouse School of Medicine, Altanta, Georgia, USA
Genet Test 7:39-44. 2003..Future research in real-life testing situations with more representative samples will be necessary to confirm these racial and cultural differences in perceptions of genetic testing...
Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County StudyConstantine G Lyketsos
Division of Geriatric Psychiatry and Neuropsychiatry, Dept of Psychiatry and Behavioral Sciences, School of Medicine, The Johns Hopkins University, Johns Hopkins Hospital, Baltimore, MD 21287, USA
Am J Geriatr Psychiatry 13:656-64. 2005..Authors investigated medical comorbidity in persons with dementia and "Cognitive Impairment, No Dementia" (CIND)...
Areas of intervention for genetic counselling of dementia: cross-cultural comparison between Italians and AmericansGiuliano Binetti
NeuroBioGen Lab Memory Clinic IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
Patient Educ Couns 64:285-93. 2006....
Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County StudyKatherine A Treiber
Department of Psychology, Utah State University, Logan, U S A
Int Psychogeriatr 20:538-53. 2008..To examine, in an exploratory analysis, the association between vascular conditions and the occurrence of neuropsychiatric symptoms (NPS) in a population-based sample of incident Alzheimer's disease (AD)...
Trail Making Test errors in normal aging, mild cognitive impairment, and dementiaLee Ashendorf
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, United States
Arch Clin Neuropsychol 23:129-37. 2008..The findings show that TMT B time and errors are independently meaningful scores, and both therefore have clinical utility in assessing individuals referred for dementia evaluations...
Epidemiology of apathy in older adults: the Cache County StudyChiadi U Onyike
Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
Am J Geriatr Psychiatry 15:365-75. 2007..The objectives of this study are to describe the distribution of apathy in community-based older adults and to investigate its relationships with cognition and day-to-day functioning...
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL StudySusan LaRusse Eckert
Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, USA
Genet Med 8:746-51. 2006..Health professionals testing for complex disorders such as Alzheimer's disease must find an appropriate balance between communicating risk in an understandable format and addressing the probabilistic nature of the information...
Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham StudyAbimbola Akomolafe
Department of Medicine, Morehouse School of Medicine, Atlanta, GA, USA
Arch Neurol 63:1551-5. 2006..28-17.72; P = .02). CONCLUSION: Diabetes mellitus did not increase the risk of incident AD in the Framingham cohort overall; however, DM may be a risk factor for AD in the absence of other known major AD risk factors...
Education effects on cognitive function in a healthy aged Arab populationRivka Inzelberg
Department of Neurology, Hillel Yaffe Medical Center, Hadera, Israel
Int Psychogeriatr 19:593-603. 2007..We investigated the influence of gender, education and occupation in a cognitively normal community sample which was assessed using an Arabic translation of the MMSE and the BCST...
Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased riskHolly C Gooding
Division of Community Health and Human Development, University of California School of Public Health, Berkeley, CA, USA
Patient Educ Couns 64:259-67. 2006..PRACTICE IMPLICATIONS: Once testing becomes clinically available, practitioners need to address the value and limitations of testing as well as appraisals and efforts to cope...
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trialPaul S Aisen
Department of Neurosciences, University of California, San Diego, 9500 Gilman Dr, M C 0949, La Jolla, CA 92093, USA
JAMA 300:1774-83. 2008..Prior studies of B vitamins to reduce homocysteine in AD have not had sufficient size or duration to assess their effect on cognitive decline...
GINA, genism, and civil rightsGeorge J Annas
Bioethics 22:ii-iv. 2008
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseEkaterina Rogaeva
Centre for Research in Neurodegenerative Diseases, Department of Medicine, Department, University of Toronto, Toronto, Ontario, Canada
Nat Genet 39:168-77. 2007..These data suggest that inherited or acquired changes in SORL1 expression or function are mechanistically involved in causing Alzheimer disease...
Research Grants
- Risk Evaluation and Education for Alzheimer's Disease (REVEAL IV)Robert C Green; Fiscal Year: 2010....
- Risk Evaluation and Education for Alzheimer's DiseaseRobert Green; Fiscal Year: 2009..This study will have an impact on public health by informing policy makers and clinicians about safe and effective ways to integrate genetic discoveries into the practice of medicine. ..
- Risk Evaluation and Education for Alzheimer's DiseaseRobert Green; Fiscal Year: 2007..This study will have an impact on public health by informing policy makers and clinicians about safe and effective ways to integrate genetic discoveries into the practice of medicine. ..
- Characterizing and Communicating Genetic Risk for Alzheimer's DiseaseRobert Green; Fiscal Year: 2007..This award will also help refine the candidate's own research skills in the area of genetic epidemiology and lay the groundwork for expanding the MIRAGE Study and the REVEAL Study in new directions. ..
- Risk Evaluation and Education for Alzheimer's DiseaseRobert Green; Fiscal Year: 2005..abstract_text> ..
- GENETIC RISK ASSESSMENT FOR ALZHEIMER'S DISEASERobert Green; Fiscal Year: 2003....
- Impact of Direct to Consumer Genetic TestingScott Roberts; Fiscal Year: 2010..This study will produce results that can be translated into recommendations to guide practice and policy in this rapidly emerging area. ..
